[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sandoz Group Ag ADR (SDZNY)

Sandoz Group Ag ADR (SDZNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 34,900,800
  • Shares Outstanding, K 440,000
  • Annual Sales, $ 11,157 M
  • Annual Income, $ 914,000 K
  • EBIT $ 0 M
  • EBITDA $ 1,425 M
  • 60-Month Beta 0.71
  • Price/Sales 3.17
  • Price/Cash Flow 22.42
  • Price/Book 3.80
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/03/26
  • Annual Dividend & Yield (Fwd) 0.62 (0.76%)
  • Most Recent Dividend 0.615 on 04/14/26
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.7900 +6.06%
on 03/30/26
88.1000 -9.97%
on 04/15/26
+3.7890 (+5.02%)
since 03/27/26
3-Month
74.7900 +6.06%
on 03/30/26
94.1500 -15.75%
on 02/25/26
-0.6050 (-0.76%)
since 01/28/26
52-Week
41.9500 +89.08%
on 04/30/25
94.1500 -15.75%
on 02/25/26
+35.2200 (+79.86%)
since 04/28/25

Most Recent Stories

More News
Barclays Reaffirms Their Buy Rating on Sandoz Group Ltd (SDZXF)

Barclays analyst Sidhartha Modi maintained a Buy rating on Sandoz Group Ltd today and set a price target of CHF55.00. The company’s shares closed last Thursday at $61.11.Elevate Your Investing Strategy:...

SDZNY : 79.3200 (-0.64%)
SDZXF : 79.9885 (-1.55%)
Should You Buy Novartis Stock Before October 28?

Novartis is gaining traction this year, but can the trend continue?

GLUE : 19.01 (-1.45%)
SDZNY : 79.3200 (-0.64%)
NVS : 145.50 (+0.91%)
Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in US

Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches ...

SDZNY : 79.3200 (-0.64%)
Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris

For Immediate ReleaseChicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS.Industry: Generic DrugsLink: https://www.zacks.com/commentary/2490523/3-generic-drug-stocks-to-watch-amid-pricing-pressure-tariff-threatsGeneric...

SDZNY : 79.3200 (-0.64%)
VTRS : 14.82 (+0.07%)
TEVA : 31.62 (+1.15%)
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing...

SDZNY : 79.3200 (-0.64%)
VTRS : 14.82 (+0.07%)
TEVA : 31.62 (+1.15%)
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals

For Immediate ReleaseChicago, IL – April 16, 2025 – Today, Zacks Equity Research Equity are Dr. Reddy’s Laboratories RDY, Sandoz SDZNY and Teva Pharmaceuticals TEVA.Industry: Generic DrugsLink: https://www.zacks.com/commentary/2448907/3-generic-drug-stocks-to-watch-amid-trade-war-jitters-inflation-woesWhile...

SDZNY : 79.3200 (-0.64%)
RDY : 14.03 (+0.43%)
TEVA : 31.62 (+1.15%)
3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from...

SDZNY : 79.3200 (-0.64%)
RDY : 14.03 (+0.43%)
TEVA : 31.62 (+1.15%)
Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share in cash,...

ITCI : 131.87 (-0.04%)
SDZNY : 79.3200 (-0.64%)
JNJ : 227.79 (+1.09%)
Why Coherus Biosciences Popped Today

Coherus is divesting its non-core ophthalmology franchise.

SDZNY : 79.3200 (-0.64%)
CHRS : 1.7700 (-3.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sandoz Group AG develops, manufactures and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars and biotechnology manufacturing services and anti-infectives, such as active pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 81.4600
2nd Resistance Point 80.5200
1st Resistance Point 79.9200
Last Price 79.3200
1st Support Level 78.3800
2nd Support Level 77.4400
3rd Support Level 76.8400

See More

52-Week High 94.1500
Last Price 79.3200
Fibonacci 61.8% 74.2096
Fibonacci 50% 68.0500
Fibonacci 38.2% 61.8904
52-Week Low 41.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.